Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Below historical average, structural decline.
Left:
||||
Year-over-year gross profit growth rate
Latest
10.25%
↓ 71% below average
Average (9y)
35.45%
Historical baseline
Range
High:74.58%
Low:9.64%
CAGR
-19.8%
Structural decline
| Period | Value |
|---|---|
| 2024 | 10.25% |
| 2023 | 9.64% |
| 2022 | 17.69% |
| 2021 | 21.96% |
| 2020 | 51.29% |
| 2019 | 37.04% |
| 2018 | 19.18% |
| 2017 | 48.39% |
| 2016 | 64.50% |
| 2015 | 74.58% |